SS
Insider
Stephen A Sherwin
DirectorStephen A Sherwin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $4.1M of NBIX (25,000 sh across 5 lots, as filed), executed Jun 5.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.1M
shares × price, as filed
Last traded
Jun 5
Filed Jun 9
Median ADV $194.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
NBIX
Neurocrine Biosciences, Inc.
NBIX · 0 buys · 2 sells
2 filings
BIIBRecent filings
NBIXSALE
Neurocrine Biosciences, Inc.
View filing →
$4.1M25,000 sh across 5 lots
Exec Jun 5
Filed Jun 9 · 5:30 PM ET BIIBSALE Biogen Inc. View filing → $1.3M
8,760 sh × $150.02
Exec Mar 7 2025
Filed Mar 10 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $1.6M
13,831 sh × $116.69
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET